Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Intravitreal Injection—Technique and Safety

Intravitreal Injection—Technique and Safety Downloaded from http://journals.lww.com/apjoo by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/01/2020 TECHNIQUE,TECHNOLOGY,PRACTICE, AND MODEL Timothy Y. Y. Lai, MD, FRCS, FRCOphth,*† Shu Liu, MD,‡§ Sudipta Das, MD,§ and Dennis S. C. Lam, MD, FRCS, FRCOphth*‡§¶ States (US), and it has been estimated that almost 6 million in- Abstract: Intravitreal (IVT) injection of therapeutic agents has become 1 jections will be carried out in 2016. Among the complications one of the most commonly performed procedures in ophthalmology. Over associated with IVT injection, endophthalmitis is one of the the past decade, a number of guidelines have been published that recom- most serious. Based on published epidemiological studies, the mend proper techniques to increase the safety of IVT injections. Among incidence of endophthalmitis after IVT anti-VEGF injection is the various complications of IVT injections, endophthalmitis can be sight 2–5 estimated to range from 0.020% to 0.085%. To prevent the threatening. The reported endophthalmitis rates after IVT injection range occurrence of endophthalmitis, a number of guidelines have from 0.020% to 0.085%, which are higher than what would be expected 6,7 been developed for the best practice of IVT injection. This ar- from a simple, fast, and relatively atraumatic procedure. The 2 key issues ticle provides perspective on http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Asia-Pacific Journal of Ophthalmology Wolters Kluwer Health

Loading next page...
 
/lp/wolters-kluwer-health/intravitreal-injection-technique-and-safety-27v24V3I2e
Publisher
Wolters Kluwer Health
ISSN
2162-0989
eISSN
2475-5028
DOI
10.1097/APO.0000000000000146
Publisher site
See Article on Publisher Site

Abstract

Downloaded from http://journals.lww.com/apjoo by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/01/2020 TECHNIQUE,TECHNOLOGY,PRACTICE, AND MODEL Timothy Y. Y. Lai, MD, FRCS, FRCOphth,*† Shu Liu, MD,‡§ Sudipta Das, MD,§ and Dennis S. C. Lam, MD, FRCS, FRCOphth*‡§¶ States (US), and it has been estimated that almost 6 million in- Abstract: Intravitreal (IVT) injection of therapeutic agents has become 1 jections will be carried out in 2016. Among the complications one of the most commonly performed procedures in ophthalmology. Over associated with IVT injection, endophthalmitis is one of the the past decade, a number of guidelines have been published that recom- most serious. Based on published epidemiological studies, the mend proper techniques to increase the safety of IVT injections. Among incidence of endophthalmitis after IVT anti-VEGF injection is the various complications of IVT injections, endophthalmitis can be sight 2–5 estimated to range from 0.020% to 0.085%. To prevent the threatening. The reported endophthalmitis rates after IVT injection range occurrence of endophthalmitis, a number of guidelines have from 0.020% to 0.085%, which are higher than what would be expected 6,7 been developed for the best practice of IVT injection. This ar- from a simple, fast, and relatively atraumatic procedure. The 2 key issues ticle provides perspective on

Journal

The Asia-Pacific Journal of OphthalmologyWolters Kluwer Health

Published: Dec 1, 2015

There are no references for this article.